We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 10
Most popular |Most recent

EMEA Healthcare Industry Group Newsletter - April 2016

Netherlands, Poland, Spain, Sweden, Turkey, United Kingdom, Belgium, European Union, France, Italy - April 12 2016 Drug companies operating in Russia and other Eurasian Economic Union ("EAEU") countries are being advised to prepare for the new obligations and...

Els Janssens, Evgeniya Shagarina, Elina Angeloudi, Sheila Mendez, Julia Gillert.

EMEA Healthcare Industry Group Newsletter - December 2015

Netherlands, Saudi Arabia, Spain, United Arab Emirates, United Kingdom, Belgium, European Union, Germany, Italy - January 25 2016 The Eurasian Economic Union (EAEU) is introducing major new changes in the marketing of pharmaceuticals across its members - which include Russia...

Els Janssens, Joost Haans, Elisabet Cots, Julia Gillert, Alexey Trusov.

Amendment of the VAT rates on pharmaceutical and medical devices

Spain - February 6 2015 Effective as of January 2015, Law 282014 of 27 November 2014 amends the VAT rates as a consequence of the need to adapt Spain's internal regulations...

Rosalia Serra.

Disclosure obligations under the EFPIA Disclosure Code entered into force on 1 January 2015

European Union - February 6 2015 The EFPIA Code on Disclosure of Transfers of Value from pharmaceutical companies to healthcare professionals and healthcare organizations (EFPIA...

Ariadna Casanueva.

One step further towards a new Spanish Reference Price System

Spain - March 17 2014 Last year, the Spanish Government initiated a legislative procedure designed to update the legislation developing the Reference Price System in Spain...

Sara Kamo.